This story has been updated to reflect that MDxHealth completed its private placement on June 29.

NEW YORK (GenomeWeb News) – MDxHealth has successfully completed a private placement that raised €10 million ($12.4 million).

Pursuant to the placement, the Belgian molecular diagnostics firm said it will issue about 2 million new ordinary shares to Bioinvest Comm. at an offer price of €1.503 and 4.9 million shares to other unnamed investors at an offer price of €1.430.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.